$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000162828022010331 Filed on April 26, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$2.302M	$2.155M
YoY Change	6.82%	-0.76%
Cost Of Revenue	$508.9K	$576.3K
YoY Change	-11.7%	-7.08%
Gross Profit	$1.794M	$1.579M
YoY Change	13.57%	1.76%
Gross Profit Margin	77.9%	73.26%
Selling, General & Admin	$2.045M	$1.406M
YoY Change	45.43%	-16.11%
% of Gross Profit	114.02%	89.04%
Research & Development	$710.6K	$233.3K
YoY Change	204.61%	-56.28%
% of Gross Profit	39.62%	14.77%
Depreciation & Amortization	$12.88K	$22.18K
YoY Change	-41.95%	-5.23%
% of Gross Profit	0.72%	1.4%
Operating Expenses	$2.756M	$1.639M
YoY Change	68.08%	-25.81%
Operating Profit	-$962.0K	-$60.20K
YoY Change	1498.12%	-90.85%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$3.430K	$0.00
YoY Change
Pretax Income	-$958.6K	-$60.00K
YoY Change	1497.6%	-90.91%
Income Tax
% Of Pretax Income
Net Earnings	-$958.6K	-$59.78K
YoY Change	1503.4%	-90.91%
Net Earnings / Revenue	-41.63%	-2.77%
Basic Earnings Per Share	-$0.14	-$0.02
Diluted Earnings Per Share	-$0.14	-$0.02
COMMON SHARES
Basic Shares Outstanding	6.893M shares	3.796M shares
Diluted Shares Outstanding	6.893M shares	3.796M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.77M	$5.150M
YoY Change	361.54%	82.62%
Cash & Equivalents	$23.80M	$5.100M
Short-Term Investments
Other Short-Term Assets	$422.6K	$360.0K
YoY Change	17.39%	5.88%
Inventory	$711.9K	$979.6K
Prepaid Expenses
Receivables	$683.3K	$477.7K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$25.59M	$6.965M
YoY Change	267.35%	42.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$184.3K	$182.8K
YoY Change	0.87%	-26.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$26.40K	$30.00K
YoY Change	-12.0%	0.0%
Total Long-Term Assets	$661.1K	$755.5K
YoY Change	-12.49%	-43.14%
TOTAL ASSETS
Total Short-Term Assets	$25.59M	$6.965M
Total Long-Term Assets	$661.1K	$755.5K
Total Assets	$26.25M	$7.721M
YoY Change	239.97%	24.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$360.9K	$381.2K
YoY Change	-5.35%	-38.82%
Accrued Expenses	$1.207M	$605.5K
YoY Change	99.34%	-43.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.727M	$2.088M
YoY Change	-17.28%	-27.55%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$283.2K	$370.0K
YoY Change	-23.46%	-54.32%
Total Long-Term Liabilities	$283.2K	$370.0K
YoY Change	-23.46%	-54.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.727M	$2.088M
Total Long-Term Liabilities	$283.2K	$370.0K
Total Liabilities	$2.010M	$2.460M
YoY Change	-18.27%	-33.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$200.1M	-$196.9M
YoY Change	1.64%	0.77%
Common Stock	$701.00	$380.00
YoY Change	84.47%	126.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.24M	$5.261M
YoY Change
Total Liabilities & Shareholders Equity	$26.25M	$7.721M
YoY Change	239.97%	24.4%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$958.6K	-$59.78K
YoY Change	1503.4%	-90.91%
Depreciation, Depletion And Amortization	$12.88K	$22.18K
YoY Change	-41.95%	-5.23%
Cash From Operating Activities	-$740.4K	-$33.79K
YoY Change	2091.12%	-95.57%
INVESTING ACTIVITIES
Capital Expenditures	$5.395K	$21.45K
YoY Change	-74.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$5.395K	-$21.45K
YoY Change	-74.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.943M	-$25.80K
YoY Change	-7630.33%	-105.69%
NET CHANGE
Cash From Operating Activities	-$740.4K	-$33.79K
Cash From Investing Activities	-$5.395K	-$21.45K
Cash From Financing Activities	$1.943M	-$25.80K
Net Change In Cash	$1.197M	-$81.05K
YoY Change	-1577.28%	-73.83%
FREE CASH FLOW
Cash From Operating Activities	-$740.4K	-$33.79K
Capital Expenditures	$5.395K	$21.45K
Free Cash Flow	-$745.8K	-$55.24K
YoY Change	1249.99%	-92.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	us-gaap	Substantial Doubt About Going Concern Within One Year SubstantialDoubtAboutGoingConcernWithinOneYear	false
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-33351
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	NEUROMETRIX, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3308180
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4B Gill Street
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
CY2022Q1	dei	City Area Code CityAreaCode	781
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	890-9989
CY2022Q1	dei	Trading Symbol TradingSymbol	NURO
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q4	us-gaap	Assets Current AssetsCurrent	24187859	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	184346	USD
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7130091	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23769380	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22572104	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	683319	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	310818	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	711936	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	706553	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	422616	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	598384	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	25587251	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	198703	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	450374	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	475230	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	26400	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	26400	USD
CY2022Q1	us-gaap	Assets Assets	26248371	USD
CY2021Q4	us-gaap	Assets Assets	24888192	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	360855	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	284036	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1207008	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	814155	USD
CY2022Q1	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	11000	USD
CY2021Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	39000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	148391	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	228506	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1727254	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1365697	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	283209	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	306709	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	222378373	USD
CY2022Q1	us-gaap	Liabilities Liabilities	2010463	USD
CY2021Q4	us-gaap	Liabilities Liabilities	1672406	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7006055	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7006055	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6694296	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6694296	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	701	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	669	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	224359025	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-200121819	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-199163257	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	24237908	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23215786	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26248371	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24888192	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2302391	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2155472	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	508874	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	576289	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	1793517	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	1579183	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	710577	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	233277	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	858839	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	393825	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1186091	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1012276	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2755507	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	1639378	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-961990	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-60195	USD
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3428	USD
CY2021Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	412	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-59783	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5247775	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	68863	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1943052	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4197	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-59783	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	5261052	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23215786	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37632	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	24237908	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-958562	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-59783	USD
CY2022Q1	us-gaap	Depreciation Depreciation	12877	USD
CY2021Q1	us-gaap	Depreciation Depreciation	22182	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	37632	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	68863	USD
CY2022Q1	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	0	USD
CY2021Q1	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	126748	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-6875	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	372501	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	143392	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5383	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-71656	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-37009	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	16043	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	76819	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	238932	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	452853	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-332953	USD
CY2022Q1	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-28000	USD
CY2021Q1	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-10000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-740381	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33790	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5395	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21453	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5395	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21453	USD
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1943052	USD
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4197	USD
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	30000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1943052	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25803	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1197276	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-81046	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22572104	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5226213	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23769380	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5145167	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23800000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	93991	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y4M24D
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</span></div>
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-59783	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6893164	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3796120	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6893164	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3796120	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	510318	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	368572	shares
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	413653	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	422093	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	298283	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	284460	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	711936	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	706553	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	156000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	109000	USD
CY2022Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	825698	USD
CY2021Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	440474	USD
CY2022Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	24800	USD
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	28400	USD
CY2022Q1	nuro	Accrued Leaseholds Current AccruedLeaseholdsCurrent	0	USD
CY2021Q4	nuro	Accrued Leaseholds Current AccruedLeaseholdsCurrent	60000	USD
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	139507	USD
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	108788	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	61003	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	67493	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1207008	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	814155	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	124339	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	165785	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165785	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	117431	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	573340	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.15
CY2022Q1	nuro	Operating Lease Discount OperatingLeaseDiscount	141740	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	148391	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	283209	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	573340	USD
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	22795	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	24754	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	166904	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	20000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	104200	USD
CY2021Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	2408	shares
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4197	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2302391	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2155472	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	1793517	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	1579183	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2755507	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	1639378	USD
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3428	USD
CY2021Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	412	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-59783	USD

Files In Submission

Name	View Source	Status
0001628280-22-010331-index-headers.html	Edgar Link	pending
0001628280-22-010331-index.html	Edgar Link	pending
0001628280-22-010331.txt	Edgar Link	pending
0001628280-22-010331-xbrl.zip	Edgar Link	pending
a10q3312022ex311.htm	Edgar Link	pending
a10q3312022ex312.htm	Edgar Link	pending
a10q3312022ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuro-20220331.htm	Edgar Link	pending
nuro-20220331.xsd	Edgar Link	pending
nuro-20220331_cal.xml	Edgar Link	unprocessable
nuro-20220331_def.xml	Edgar Link	unprocessable
nuro-20220331_htm.xml	Edgar Link	completed
nuro-20220331_lab.xml	Edgar Link	unprocessable
nuro-20220331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2022 Q1 Form 10-Q Financial Statement

#000162828022010331 Filed on April 26, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2022 Q1 Form 10-Q Financial Statement

#000162828022010331 Filed on April 26, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro